Company Filing History:
1 out of 1 
1 out of 1 
1 out of 832,843 Years Active: 2015
Title: Tuo-Ping Luo: Innovator in Cancer Treatment
Introduction
Tuo-Ping Luo is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for cancer treatment. His innovative approach has led to advancements in the synthesis of compounds that may aid in combating non-small cell lung cancer.
Latest Patents
Tuo-Ping Luo holds a patent for a method of chemical synthesis of antrocin and its use in suppressing non-small cell lung cancer. The patent describes a process for preparing antrocin and its pharmaceutically acceptable salts through a series of gold-catalyzed cyclizations to construct a (6-6-5) tricyclic core frame. This invention also outlines the use of a composition that includes an effective amount of antrocin or its salts, combined with a pharmaceutically acceptable carrier, for the preparation of drugs aimed at inhibiting the growth of non-small cell lung cancer cells.
Career Highlights
Throughout his career, Tuo-Ping Luo has worked with various companies, including Kaiyew Investment Corporation. His expertise in chemical synthesis and drug development has positioned him as a valuable contributor to the pharmaceutical industry.
Collaborations
Tuo-Ping Luo has collaborated with notable professionals in his field, including Zhen Yang and Yew-Min Tzeng. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in cancer treatment.
Conclusion
Tuo-Ping Luo's work in the synthesis of antrocin represents a significant advancement in the fight against non-small cell lung cancer. His contributions to pharmaceutical chemistry continue to inspire further research and innovation in the field.